Organogenesis

organogenesis.com · Canton, United States of America

Organogenesis is a regenerative medicine company that develops, manufactures, and commercializes advanced wound care and surgical biologic products for hospitals, outpatient wound centers, and physician offices. Its portfolio includes cellular and acellular tissue-based products used to treat chronic and acute wounds, as well as products for surgical and sports medicine applications. The company generates revenue by selling these FDA-regulated biologic and medical device products through direct sales and distributor channels primarily in the United States and select international markets.

  • Electronic Health Records
Revenue
$450.0M
Employees
1,000
Founded
1985
Headquarters
Canton, United States of America

What 14 Arbolus experts think of Organogenesis

NPS data is strongly positive, with 69% of responses in the 8–10 range and only minor representation in lower score bands. Renewal intent is high among high spenders and Influencers, while some Users remain unsure, particularly in early adoption stages. Stickiness shows a majority with over 1 year of implementation, pointing to entrenched usage. Key themes include satisfaction with product efficacy and confidence in renewal among invested accounts.Overall Customer Sentiment: Positive

Who reviewed Organogenesis

Total customers 14 14 current · 0 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 85% (12)
  • Director 15% (2)
Other Generalist Director NPS 10 Will renew
Other Generalist C-Suite NPS 3 Undecided
Other Generalist C-Suite NPS 7

Employer names and spend open once the report publishes.

Tell us when the Organogenesis report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

0 Net Promoter Score, from 14 scored reviews
  • Promoters 2
  • Passives 10
  • Detractors 2

Cumulative NPS by month

+3 over 5 months
  • Dec 5
  • Mar 6
  • Jul 7
  • Aug 7
  • Sep 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 0 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 2
  • Undecided 3
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 3 answers
  • Director 100% 2 answers
  • 9/10 Average score from customers who will renew
  • 5.3/10 Average score from undecided customers

For people who use Organogenesis

Do you use Organogenesis at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 14 customers of Organogenesis have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.